Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionmRNA binding

NCL ZCCHC13

6.91e-0369442GO:0003729
GeneOntologyBiologicalProcessRNA splicing

NCL FAM98A SFPQ

5.63e-0550243GO:0008380
GeneOntologyBiologicalProcesspositive regulation of gene expression

NCL FAM98A ZCCHC13

1.30e-03144643GO:0010628
GeneOntologyBiologicalProcessRNA processing

NCL FAM98A SFPQ

1.45e-03150043GO:0006396
GeneOntologyBiologicalProcessmRNA splicing, via spliceosome

NCL SFPQ

1.76e-0335842GO:0000398
GeneOntologyBiologicalProcessRNA splicing, via transesterification reactions with bulged adenosine as nucleophile

NCL SFPQ

1.76e-0335842GO:0000377
GeneOntologyBiologicalProcessRNA splicing, via transesterification reactions

NCL SFPQ

1.80e-0336242GO:0000375
GeneOntologyBiologicalProcessregulation of translation

NCL ZCCHC13

3.33e-0349442GO:0006417
GeneOntologyBiologicalProcessmRNA processing

NCL SFPQ

4.12e-0355142GO:0006397
DomainRRM_1

NCL SFPQ

7.30e-0420842PF00076
DomainRRM

NCL SFPQ

7.94e-0421742SM00360
DomainRRM_dom

NCL SFPQ

8.68e-0422742IPR000504
DomainRRM

NCL SFPQ

8.91e-0423042PS50102
Domain-

NCL SFPQ

1.00e-03244423.30.70.330
DomainNucleotide-bd_a/b_plait

NCL SFPQ

1.12e-0325842IPR012677
PathwayWP_MRNA_PROCESSING

NCL SFPQ

1.02e-0345122MM15946
PathwayREACTOME_INFECTIOUS_DISEASE

NCL SFPQ

5.88e-03108122M27548
Pubmed

SPOP attenuates migration and invasion of choriocarcinoma cells by promoting DHX9 degradation.

NCL FAM98A SFPQ

2.04e-071304332905556
Pubmed

Dido3-dependent SFPQ recruitment maintains efficiency in mammalian alternative splicing.

NCL SFPQ

2.08e-0774230931476
Pubmed

Interactome Analysis Reveals a Novel Role for RAD6 in the Regulation of Proteasome Activity and Localization in Response to DNA Damage.

NCL FAM98A SFPQ

2.08e-071314328031328
Pubmed

SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication.

NCL FAM98A SFPQ

9.41e-072164337640791
Pubmed

Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.

NCL FAM98A SFPQ

1.64e-062604336199071
Pubmed

A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.

NCL SFPQ ZCCHC13

3.91e-063474316033648
Pubmed

Proteomic analysis of complexes formed by human topoisomerase I.

NCL SFPQ

4.92e-06324215848144
Pubmed

The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.

NCL FAM98A SFPQ

5.99e-064004335013556
Pubmed

Endogenous human MDM2-C is highly expressed in human cancers and functions as a p53-independent growth activator.

NCL SFPQ

6.24e-06364224147044
Pubmed

Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.

NCL FAM98A SFPQ

6.98e-064214334650049
Pubmed

TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.

NCL FAM98A SFPQ

7.44e-064304338172120
Pubmed

New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.

NCL FAM98A SFPQ

9.22e-064624331138677
Pubmed

Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1.

NCL SFPQ

9.81e-06454233596420
Pubmed

AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.

NCL FAM98A SFPQ

1.06e-054844331995728
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

NCL FAM98A SFPQ

1.13e-054944326831064
Pubmed

Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer.

NCL SFPQ

1.31e-05524224591637
Pubmed

Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.

NCL FAM98A SFPQ

1.56e-055514334728620
Pubmed

Regulation of alternative splicing by SRrp86 and its interacting proteins.

NCL SFPQ

1.58e-05574214559993
Pubmed

Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system.

FAM98A SFPQ

1.75e-05604229055695
Pubmed

LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.

NCL FAM98A SFPQ

1.82e-055804335676659
Pubmed

DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.

NCL SFPQ

1.93e-05634237052853
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

NCL FAM98A SFPQ

2.07e-056054328977666
Pubmed

WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.

NCL FAM98A SFPQ

2.17e-056154331048545
Pubmed

Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.

NCL FAM98A SFPQ

2.29e-056264333644029
Pubmed

Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.

NCL FAM98A SFPQ

2.74e-056654330457570
Pubmed

Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion.

NCL FAM98A SFPQ

3.25e-057044332994395
Pubmed

RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.

NCL FAM98A SFPQ

3.38e-057134329802200
Pubmed

Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis.

NCL SFPQ

3.45e-05844219135240
Pubmed

Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.

NCL FAM98A SFPQ

3.52e-057234334133714
Pubmed

Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.

NCL FAM98A SFPQ

3.55e-057254327025967
Pubmed

Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.

NCL FAM98A SFPQ

3.64e-057314329298432
Pubmed

HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.

NCL FAM98A SFPQ

3.99e-057544335906200
Pubmed

Proteomics analysis of the estrogen receptor alpha receptosome.

NCL SFPQ

4.23e-05934220348541
Pubmed

Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations.

NCL SFPQ

4.51e-05964225948554
Pubmed

Insights into specificity, redundancy and new cellular functions of C/EBPa and C/EBPb transcription factors through interactome network analysis.

NCL SFPQ

4.79e-05994227746211
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

NCL FAM98A SFPQ

4.89e-058074322681889
Pubmed

Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.

NCL FAM98A SFPQ

5.59e-058444325963833
Pubmed

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

NCL FAM98A SFPQ

5.65e-058474335850772
Pubmed

Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.

NCL FAM98A SFPQ

5.65e-058474335235311
Pubmed

TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.

NCL FAM98A SFPQ

7.28e-059224327609421
Pubmed

Elucidation of the 14-3-3ζ interactome reveals critical roles of RNA-splicing factors during adipogenesis.

FAM98A SFPQ

7.29e-051224229530978
Pubmed

Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL.

NCL SFPQ

7.41e-051234235583604
Pubmed

Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.

NCL SFPQ

7.53e-051244220850016
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

NCL FAM98A SFPQ

8.06e-059544336373674
Pubmed

In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.

NCL FAM98A SFPQ

8.50e-059714333306668
Pubmed

Identification of 14-3-3epsilon substrates from embryonic murine brain.

NCL SFPQ

8.54e-051324216944949
Pubmed

Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.

NCL SFPQ

9.06e-051364226979993
Pubmed

Landscape of the SOX2 protein-protein interactome.

NCL FAM98A

9.06e-051364221280222
Pubmed

High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.

NCL FAM98A SFPQ

9.87e-0510214326760575
Pubmed

LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.

NCL SFPQ

9.88e-051424230809309
Pubmed

HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.

NCL SFPQ

1.07e-041484232538781
Pubmed

Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin.

NCL SFPQ

1.09e-041494226370502
Pubmed

Identification of intracellular proteins associated with the EBV-encoded nuclear antigen 5 using an efficient TAP procedure and FT-ICR mass spectrometry.

NCL SFPQ

1.12e-041514218457437
Pubmed

Proteomic analysis of the cullin 4B interactome using proximity-dependent biotinylation in living cells.

NCL SFPQ

1.15e-041534228225217
InteractionUBE2A interactions

NCL FAM98A SFPQ

5.52e-0622643int:UBE2A
InteractionATXN1 interactions

NCL FAM98A SFPQ ZCCHC13

7.03e-06103944int:ATXN1
InteractionTRIM31 interactions

NCL FAM98A SFPQ

4.47e-0545443int:TRIM31
InteractionSPOP interactions

NCL FAM98A SFPQ

5.65e-0549143int:SPOP
InteractionPSPC1 interactions

NCL FAM98A SFPQ

6.51e-0551543int:PSPC1
InteractionTARDBP interactions

NCL FAM98A SFPQ

6.70e-0552043int:TARDBP
InteractionMIR138-1 interactions

FAM98A SFPQ

6.70e-056842int:MIR138-1
InteractionMIR9-3 interactions

FAM98A SFPQ

7.10e-057042int:MIR9-3
InteractionMIR140 interactions

FAM98A SFPQ

7.31e-057142int:MIR140
InteractionMIR29B1 interactions

FAM98A SFPQ

7.73e-057342int:MIR29B1
InteractionMIR18A interactions

FAM98A SFPQ

7.73e-057342int:MIR18A
InteractionMIR20A interactions

FAM98A SFPQ

7.94e-057442int:MIR20A
InteractionMIR15A interactions

FAM98A SFPQ

8.16e-057542int:MIR15A
InteractionMIR16-1 interactions

FAM98A SFPQ

8.38e-057642int:MIR16-1
InteractionMIR7-3 interactions

FAM98A SFPQ

8.38e-057642int:MIR7-3
InteractionMIR199A2 interactions

FAM98A SFPQ

8.38e-057642int:MIR199A2
InteractionMIR9-2 interactions

FAM98A SFPQ

8.60e-057742int:MIR9-2
InteractionMIR200A interactions

FAM98A SFPQ

8.60e-057742int:MIR200A
InteractionMIR98 interactions

FAM98A SFPQ

8.83e-057842int:MIR98
InteractionMIR222 interactions

FAM98A SFPQ

9.06e-057942int:MIR222
InteractionMIR34C interactions

FAM98A SFPQ

9.06e-057942int:MIR34C
InteractionMIR1-2 interactions

FAM98A SFPQ

9.06e-057942int:MIR1-2
InteractionMIR143 interactions

FAM98A SFPQ

9.29e-058042int:MIR143
InteractionMIR145 interactions

FAM98A SFPQ

9.52e-058142int:MIR145
InteractionLGALS9 interactions

NCL FAM98A SFPQ

9.67e-0558843int:LGALS9
InteractionPPARGC1A interactions

NCL SFPQ

9.76e-058242int:PPARGC1A
InteractionMIR10B interactions

FAM98A SFPQ

9.76e-058242int:MIR10B
InteractionMIR106A interactions

FAM98A SFPQ

1.00e-048342int:MIR106A
InteractionMIR200B interactions

FAM98A SFPQ

1.02e-048442int:MIR200B
InteractionMIR7-2 interactions

FAM98A SFPQ

1.02e-048442int:MIR7-2
InteractionMIR31 interactions

FAM98A SFPQ

1.02e-048442int:MIR31
InteractionMIR199A1 interactions

FAM98A SFPQ

1.02e-048442int:MIR199A1
InteractionMIR16-2 interactions

FAM98A SFPQ

1.05e-048542int:MIR16-2
InteractionMIR93 interactions

FAM98A SFPQ

1.05e-048542int:MIR93
InteractionMIR9-1 interactions

FAM98A SFPQ

1.05e-048542int:MIR9-1
InteractionMIR107 interactions

FAM98A SFPQ

1.05e-048542int:MIR107
InteractionMIR17 interactions

FAM98A SFPQ

1.05e-048542int:MIR17
InteractionMIR18B interactions

FAM98A SFPQ

1.05e-048542int:MIR18B
InteractionMIR20B interactions

FAM98A SFPQ

1.07e-048642int:MIR20B
InteractionMIR29A interactions

FAM98A SFPQ

1.10e-048742int:MIR29A
InteractionMIR141 interactions

FAM98A SFPQ

1.12e-048842int:MIR141
InteractionMIR29C interactions

FAM98A SFPQ

1.15e-048942int:MIR29C
InteractionMIR221 interactions

FAM98A SFPQ

1.18e-049042int:MIR221
InteractionMIR92A2 interactions

FAM98A SFPQ

1.18e-049042int:MIR92A2
InteractionMIR200C interactions

FAM98A SFPQ

1.20e-049142int:MIR200C
InteractionMIR128-1 interactions

FAM98A SFPQ

1.23e-049242int:MIR128-1
InteractionMIR155 interactions

FAM98A SFPQ

1.23e-049242int:MIR155
InteractionMIR214 interactions

FAM98A SFPQ

1.26e-049342int:MIR214
InteractionMIR205 interactions

FAM98A SFPQ

1.26e-049342int:MIR205
InteractionMIR19B2 interactions

FAM98A SFPQ

1.28e-049442int:MIR19B2
InteractionMIRLET7F1 interactions

FAM98A SFPQ

1.28e-049442int:MIRLET7F1
InteractionMIRLET7A2 interactions

FAM98A SFPQ

1.34e-049642int:MIRLET7A2
InteractionMIRLET7C interactions

FAM98A SFPQ

1.37e-049742int:MIRLET7C
InteractionMIR21 interactions

FAM98A SFPQ

1.37e-049742int:MIR21
InteractionMIRLET7F2 interactions

FAM98A SFPQ

1.37e-049742int:MIRLET7F2
InteractionMIR363 interactions

FAM98A SFPQ

1.37e-049742int:MIR363
InteractionMIR128-2 interactions

FAM98A SFPQ

1.42e-049942int:MIR128-2
InteractionMIR19A interactions

FAM98A SFPQ

1.45e-0410042int:MIR19A
InteractionRC3H1 interactions

NCL FAM98A SFPQ

1.47e-0467743int:RC3H1
InteractionMIRLET7B interactions

FAM98A SFPQ

1.48e-0410142int:MIRLET7B
InteractionMIRLET7D interactions

FAM98A SFPQ

1.48e-0410142int:MIRLET7D
InteractionMIR25 interactions

FAM98A SFPQ

1.48e-0410142int:MIR25
InteractionMIRLET7A3 interactions

FAM98A SFPQ

1.51e-0410242int:MIRLET7A3
InteractionMIR7-1 interactions

FAM98A SFPQ

1.54e-0410342int:MIR7-1
InteractionMIR15B interactions

FAM98A SFPQ

1.54e-0410342int:MIR15B
InteractionMIR34A interactions

FAM98A SFPQ

1.57e-0410442int:MIR34A
InteractionMIR19B1 interactions

FAM98A SFPQ

1.57e-0410442int:MIR19B1
InteractionMIRLET7E interactions

FAM98A SFPQ

1.63e-0410642int:MIRLET7E
InteractionMIRLET7A1 interactions

FAM98A SFPQ

1.70e-0410842int:MIRLET7A1
InteractionMIR34B interactions

FAM98A SFPQ

1.76e-0411042int:MIR34B
InteractionRPS16 interactions

NCL FAM98A SFPQ

1.80e-0472443int:RPS16
InteractionMIRLET7I interactions

FAM98A SFPQ

1.89e-0411442int:MIRLET7I
InteractionMIRLET7G interactions

FAM98A SFPQ

1.99e-0411742int:MIRLET7G
InteractionSCARNA22 interactions

NCL SFPQ

2.02e-0411842int:SCARNA22
InteractionCHD3 interactions

NCL FAM98A SFPQ

2.05e-0475743int:CHD3
InteractionFUS interactions

NCL FAM98A SFPQ

2.05e-0475743int:FUS
InteractionBTRC interactions

NCL FAM98A SFPQ

2.20e-0477543int:BTRC
InteractionBTF3 interactions

NCL FAM98A SFPQ

2.41e-0479943int:BTF3
InteractionDOT1L interactions

NCL FAM98A SFPQ

2.48e-0480743int:DOT1L
InteractionMAU2 interactions

NCL SFPQ

2.69e-0413642int:MAU2
InteractionWWP2 interactions

NCL FAM98A SFPQ

2.80e-0484043int:WWP2
InteractionLINC01554 interactions

NCL SFPQ

2.93e-0414242int:LINC01554
InteractionZC3H18 interactions

NCL FAM98A SFPQ

3.18e-0487743int:ZC3H18
InteractionHTATSF1 interactions

NCL SFPQ

3.58e-0415742int:HTATSF1
InteractionHEXIM1 interactions

NCL FAM98A SFPQ

3.58e-0491343int:HEXIM1
InteractionPRMT1 interactions

NCL FAM98A SFPQ

3.77e-0492943int:PRMT1
InteractionHDAC6 interactions

NCL FAM98A SFPQ

3.77e-0492943int:HDAC6
InteractionOGT interactions

NCL FAM98A SFPQ

4.03e-0495043int:OGT
InteractionTNIP2 interactions

NCL FAM98A SFPQ

4.06e-0495243int:TNIP2
InteractionITGB3 interactions

NCL SFPQ

4.20e-0417042int:ITGB3
InteractionPHF5A interactions

NCL SFPQ

4.25e-0417142int:PHF5A
InteractionSNRNP70 interactions

NCL FAM98A SFPQ

4.47e-0498443int:SNRNP70
InteractionHECTD1 interactions

NCL FAM98A SFPQ

4.47e-0498443int:HECTD1
InteractionDIDO1 interactions

NCL SFPQ

4.50e-0417642int:DIDO1
InteractionPPP1R10 interactions

FAM98A SFPQ

4.65e-0417942int:PPP1R10
InteractionSMC5 interactions

NCL FAM98A SFPQ

4.69e-04100043int:SMC5
InteractionEXOSC2 interactions

NCL SFPQ

4.70e-0418042int:EXOSC2
InteractionSREK1 interactions

NCL SFPQ

4.86e-0418342int:SREK1
GeneFamilyRNA binding motif containing

NCL SFPQ

4.11e-0421332725
CoexpressionKRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN

NCL FAM98A SFPQ

1.85e-0495043M19907
CoexpressionDARWICHE_SQUAMOUS_CELL_CARCINOMA_UP

NCL SFPQ

2.02e-0415342M1139
CoexpressionDARWICHE_PAPILLOMA_RISK_HIGH_UP

NCL SFPQ

2.04e-0415442M1135
CoexpressionDARWICHE_PAPILLOMA_RISK_LOW_UP

NCL SFPQ

2.43e-0416842M1133
CoexpressionKRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN

NCL FAM98A SFPQ

2.45e-04104543M8525
CoexpressionDARWICHE_PAPILLOMA_RISK_HIGH_UP

NCL SFPQ

2.64e-0417542MM499
CoexpressionDARWICHE_SQUAMOUS_CELL_CARCINOMA_UP

NCL SFPQ

2.64e-0417542MM501
CoexpressionHOUNKPE_HOUSEKEEPING_GENES

NCL FAM98A SFPQ

3.09e-04112943M42508
CoexpressionGSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN

FAM98A ZCCHC13

3.14e-0419142M4180
CoexpressionDARWICHE_PAPILLOMA_RISK_LOW_UP

NCL SFPQ

3.17e-0419242MM497
CoexpressionHOUNKPE_HOUSEKEEPING_GENES

NCL FAM98A SFPQ

3.33e-04115843MM1338
CoexpressionGSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP

NCL SFPQ

3.41e-0419942M4473
CoexpressionGSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN

NCL SFPQ

3.41e-0419942M3186
CoexpressionGSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP

NCL FAM98A

3.44e-0420042M4613
CoexpressionHALLMARK_G2M_CHECKPOINT

NCL SFPQ

3.44e-0420042M5901
CoexpressionGSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN

NCL SFPQ

3.44e-0420042M3188
CoexpressionTABULA_MURIS_SENIS_LIMB_MUSCLE_T_CELL_AGEING

NCL SFPQ

4.79e-0423642MM3743
CoexpressionBUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS

NCL SFPQ

7.97e-0430542M40025
CoexpressionBUSSLINGER_DUODENAL_STEM_CELLS

NCL SFPQ

8.29e-0431142M40024
CoexpressionFAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL

NCL SFPQ

1.23e-0338042M41703
CoexpressionMONNIER_POSTRADIATION_TUMOR_ESCAPE_UP

FAM98A SFPQ

1.42e-0340842M11891
CoexpressionMONNIER_POSTRADIATION_TUMOR_ESCAPE_UP

FAM98A SFPQ

1.47e-0341542MM1028
CoexpressionMARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN

NCL SFPQ

2.29e-0351942M3395
CoexpressionMARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN

NCL SFPQ

2.50e-0354342MM997
CoexpressionFEVR_CTNNB1_TARGETS_DN

NCL SFPQ

2.61e-0355542M2343
CoexpressionTIEN_INTESTINE_PROBIOTICS_24HR_UP

FAM98A SFPQ

2.67e-0356142M1463
CoexpressionCAIRO_HEPATOBLASTOMA_CLASSES_UP

NCL SFPQ

3.17e-0361242M4772
CoexpressionBENPORATH_SOX2_TARGETS

FAM98A SFPQ

4.53e-0373442M3835
CoexpressionKIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP

NCL FAM98A

4.78e-0375542M2105
CoexpressionPUJANA_CHEK2_PCC_NETWORK

NCL SFPQ

4.86e-0376142M11961
CoexpressionJOHNSTONE_PARVB_TARGETS_3_DN

FAM98A SFPQ

6.41e-0387742M2241
CoexpressionLEE_BMP2_TARGETS_DN

FAM98A SFPQ

6.81e-0390442M2325
CoexpressionBUSSLINGER_DUODENAL_IMMUNE_CELLS

NCL SFPQ

6.91e-0391142M40038
CoexpressionLEE_BMP2_TARGETS_DN

FAM98A SFPQ

7.07e-0392242MM1068
CoexpressionTABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING

NCL SFPQ

1.08e-02114442MM3843
CoexpressionMURARO_PANCREAS_DUCTAL_CELL

NCL SFPQ

1.33e-02127642M39173
CoexpressionPUJANA_ATM_PCC_NETWORK

NCL SFPQ

1.58e-02139442M9585
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3

NCL FAM98A SFPQ

6.14e-0553243Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlasFacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5

NCL SFPQ

4.53e-0418642Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlasDevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500

NCL SFPQ

5.39e-0420342gudmap_developingGonad_e11.5_testes_k2_500
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5

NCL FAM98A

5.44e-0420442Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlasDevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_500

NCL SFPQ

7.58e-0424142gudmap_developingGonad_e12.5_testes_k4_500
CoexpressionAtlasDevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#1_top-relative-expression-ranked_1000

NCL SFPQ

7.58e-0424142gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k1
CoexpressionAtlasFacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5

NCL SFPQ

1.42e-0333142Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5
CoexpressionAtlasDevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000

NCL SFPQ

1.58e-0334942gudmap_developingGonad_P2_testes_1000_k2
CoexpressionAtlasDevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000

NCL SFPQ

1.85e-0337842gudmap_developingGonad_e16.5_testes_1000_k3
CoexpressionAtlasDevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500

NCL SFPQ

2.13e-0340642gudmap_developingGonad_e12.5_testes_500
CoexpressionAtlasDevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000

NCL SFPQ

2.38e-0342942gudmap_developingGonad_e14.5_ testes_1000_k5
CoexpressionAtlasDevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500

NCL SFPQ

2.47e-0343742gudmap_developingGonad_e11.5_testes_500
CoexpressionAtlasFacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1

NCL FAM98A

2.84e-0346942Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlasFacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500

NCL SFPQ

3.12e-0349242Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlasDevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000

NCL SFPQ

3.19e-0349842gudmap_developingGonad_e11.5_testes_k5_1000
CoexpressionAtlasDevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000

NCL SFPQ

3.53e-0352442gudmap_developingGonad_e12.5_testes_k1_1000
CoexpressionAtlasDevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000

NCL SFPQ

3.65e-0353342gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NCL SFPQ

1.00e-0418542e913c64f9b4873443d88dce270f0b7b6d1b4cbce
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NCL SFPQ

1.06e-0419042d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCellE15.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

NCL SFPQ

1.08e-04192424a0fb4ef8a9281489ffb0881421c9d691c52019c
ToppCelldroplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NCL SFPQ

1.10e-0419442e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue

NCL SFPQ

1.11e-0419542972b09697b7b66fb8a27dfc0c0b05a844121f055
ToppCell10x5'-Liver-Lymphocytic_T_CD4/8-lo|Liver / Manually curated celltypes from each tissue

NCL SFPQ

1.11e-0419542c29c4ae95a756e3ced0f0747bbfe343590e5b8ab
ToppCell3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NCL SFPQ

1.15e-041984277517df37dc894c78ef1e2b24dd7ba31f928bdb7
ToppCellmegakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class

NCL SFPQ

1.16e-041994299a65887d3c8a2cde26693dd74404b101bba9d58
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

NCL SFPQ

1.17e-042004212f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellCOVID-19|World / Disease, condition lineage and cell class

NCL SFPQ

1.17e-04200427dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NCL SFPQ

1.17e-042004248d79c7a9a2d3c10b41e152baf28fb00a4729e48
ComputationalNeighborhood of TDG

NCL SFPQ

3.08e-053532GNF2_TDG
ComputationalNeighborhood of DEK

NCL SFPQ

8.55e-055832GNF2_DEK
ComputationalNeighborhood of KPNB1

NCL SFPQ

1.36e-047332GNF2_KPNB1
ComputationalNeighborhood of XRCC5

NCL SFPQ

1.43e-047532GNF2_XRCC5
ComputationalNeighborhood of APEX1

NCL SFPQ

2.16e-049232GNF2_APEX1
ComputationalGenes in the cancer module 32.

NCL SFPQ

1.48e-0324132MODULE_32
Drugbromovanin

NCL SFPQ

1.84e-0412742ctd:C515564
Drug4-vinyl-1-cyclohexene dioxide

NCL SFPQ

3.29e-0417042ctd:C012606
DrugOxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HG-U133A

NCL SFPQ

4.42e-04197421903_DN
Drugtrovafloxacin

FAM98A SFPQ

1.55e-0337142ctd:C080163
Drugafimoxifene

NCL SFPQ

2.58e-0347942ctd:C016601
Drugfulvestrant

NCL SFPQ

2.63e-0348442ctd:C070081
Drugcupric oxide

NCL SFPQ

3.30e-0354342ctd:C030973
DrugMethoxychlor

NCL SFPQ

3.37e-0354942ctd:D008731
DrugBuspirone

FAM98A SFPQ

4.31e-0362242ctd:D002065
DrugPolychlorinated Biphenyls

FAM98A SFPQ

4.46e-0363342ctd:D011078
Drugbromfenacoum

NCL SFPQ

4.61e-0364442ctd:C013418
DrugKetamine

FAM98A SFPQ

7.02e-0379842ctd:D007649
DrugRaloxifene Hydrochloride

NCL SFPQ

8.07e-0385742ctd:D020849
Diseasebalding measurement

NCL ZCCHC13

4.16e-0379242EFO_0007825

Protein segments in the cluster

PeptideGeneStartEntry
GRGGFRGGRGGGGDH

NCL

686

P19338
RGGHEQGGGRGGRGG

FAM98A

351

Q8NCA5
GGRGGYDHGGRGGGR

FAM98A

361

Q8NCA5
GGHHGDRGGGRGGRG

FAM98A

451

Q8NCA5
GGGGGFHRRGGGGGR

SFPQ

11

P23246
RGGAGGRRGGGHGRG

ZCCHC13

21

Q8WW36